Cart
sales@molnova.com
Paquinimod
CAS No. 248282-01-1
Paquinimod ( ABR 25757 )
Catalog No. M20732 CAS No. 248282-01-1
Paquinimod is a S100A9 inhibitor preventing S100A9 binding to TLR-4.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 68 | In Stock |
|
| 10MG | 111 | In Stock |
|
| 25MG | 206 | In Stock |
|
| 50MG | 336 | In Stock |
|
| 100MG | 426 | In Stock |
|
| 500MG | 1251 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePaquinimod
-
NoteResearch use only not for human use.
-
Brief DescriptionPaquinimod is a S100A9 inhibitor preventing S100A9 binding to TLR-4.
-
DescriptionPaquinimod is a S100A9 inhibitor preventing S100A9 binding to TLR-4.
-
SynonymsABR 25757
-
PathwayOthers
-
TargetOther Targets
-
RecptorS100A9
-
Research AreaOthers
-
IndicationSystemic scleroderma
Chemical Information
-
CAS Number248282-01-1
-
Formula Weight350.41
-
Molecular FormulaC21H22N2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (356.72 mM)
-
SMILESCCN(C(=O)c1c(O)c2c(CC)cccc2n(C)c1=O)c1ccccc1
-
Chemical NameN5-diethyl-4-hydroxy-1-methyl-2-oxo-N-phenyl-12-dihydroquinoline-3-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Schelbergen R F Geven E J Van d B M H J et al. Prophylactic treatment with S100A9 inhibitor paquinimod reduces pathology in experimental collagenase-induced osteoarthritis[J]. Annals of the Rheumatic Diseases 2015:annrheumdis-2014-206517.
molnova catalog
related products
-
Rhynchophylline
Rhynchophylline can protect against ischemic damage, probably via regulating the Akt/mTOR pathway.
-
8-epidiosbulbin E ac...
8-Epidiosbulbin E acetate (EEA) a furanoid was unexpectedly found to be the most abundant diterpenoid lactone in certain varieties of Dioscorea bulbifera L. (DB) a traditional herbal medicine widely used in Asian nations.
-
N-Formyl-Nle-Leu-Phe...
N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys TFA (For-Nle-Leu-Phe-Nle-Tyr-Lys-OH TFA) is a formyl peptide receptor (FPR) agonist.The derivative of this peptide is also biologically active as judged by its ability to elicit superoxide anion production by human PMNL at nanomolar concentrations.
